342 related articles for article (PubMed ID: 35958548)
21. Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike.
Changrob S; Fu Y; Guthmiller JJ; Halfmann PJ; Li L; Stamper CT; Dugan HL; Accola M; Rehrauer W; Zheng NY; Huang M; Wang J; Erickson SA; Utset HA; Graves HM; Amanat F; Sather DN; Krammer F; Kawaoka Y; Wilson PC
mBio; 2021 Dec; 12(6):e0297521. PubMed ID: 34781736
[TBL] [Abstract][Full Text] [Related]
22. The Evolution and Biology of SARS-CoV-2 Variants.
Telenti A; Hodcroft EB; Robertson DL
Cold Spring Harb Perspect Med; 2022 May; 12(5):. PubMed ID: 35444005
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
Kuba K; Yamaguchi T; Penninger JM
Front Immunol; 2021; 12():732690. PubMed ID: 35003058
[TBL] [Abstract][Full Text] [Related]
24. Computational decomposition reveals reshaping of the SARS-CoV-2-ACE2 interface among viral variants expressing the N501Y mutation.
Socher E; Conrad M; Heger L; Paulsen F; Sticht H; Zunke F; Arnold P
J Cell Biochem; 2021 Dec; 122(12):1863-1872. PubMed ID: 34516024
[TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 Variants of Concern and Variants of Interest Receptor Binding Domain Mutations and Virus Infectivity.
Liu H; Wei P; Kappler JW; Marrack P; Zhang G
Front Immunol; 2022; 13():825256. PubMed ID: 35154144
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.
Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS
J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235
[TBL] [Abstract][Full Text] [Related]
27. Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.
Melo-González F; Soto JA; González LA; Fernández J; Duarte LF; Schultz BM; Gálvez NMS; Pacheco GA; Ríos M; Vázquez Y; Rivera-Pérez D; Moreno-Tapia D; Iturriaga C; Vallejos OP; Berríos-Rojas RV; Hoppe-Elsholz G; Urzúa M; Bruneau N; Fasce RA; Mora J; Grifoni A; Sette A; Weiskopf D; Zeng G; Meng W; González-Aramundiz JV; González PA; Abarca K; Ramírez E; Kalergis AM; Bueno SM
Front Immunol; 2021; 12():747830. PubMed ID: 34858404
[TBL] [Abstract][Full Text] [Related]
28. How Do Point Mutations Enhancing the Basic Character of the RBDs of SARS-CoV-2 Variants Affect Their Transmissibility and Infectivity Capacities?
Barre A; Klonjkowski B; Benoist H; Rougé P
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458513
[TBL] [Abstract][Full Text] [Related]
29. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
Huang SW; Miller SO; Yen CH; Wang SF
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
[TBL] [Abstract][Full Text] [Related]
30. Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1.
Geng Q; Shi K; Ye G; Zhang W; Aihara H; Li F
J Virol; 2022 Apr; 96(8):e0024922. PubMed ID: 35343765
[TBL] [Abstract][Full Text] [Related]
31. Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions.
Dhawan M; Sharma A; Priyanka ; Thakur N; Rajkhowa TK; Choudhary OP
Hum Vaccin Immunother; 2022 Nov; 18(5):2068883. PubMed ID: 35507895
[TBL] [Abstract][Full Text] [Related]
32. Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk.
Chen P; Wang J; Xu X; Li Y; Zhu Y; Li X; Li M; Hao P
Comput Biol Chem; 2022 Feb; 96():107613. PubMed ID: 34896769
[TBL] [Abstract][Full Text] [Related]
33. Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains.
Qing E; Kicmal T; Kumar B; Hawkins GM; Timm E; Perlman S; Gallagher T
mBio; 2021 Aug; 12(4):e0159021. PubMed ID: 34340537
[TBL] [Abstract][Full Text] [Related]
34. Structural dynamics in the evolution of SARS-CoV-2 spike glycoprotein.
Calvaresi V; Wrobel AG; Toporowska J; Hammerschmid D; Doores KJ; Bradshaw RT; Parsons RB; Benton DJ; Roustan C; Reading E; Malim MH; Gamblin SJ; Politis A
Nat Commun; 2023 Mar; 14(1):1421. PubMed ID: 36918534
[TBL] [Abstract][Full Text] [Related]
35. Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor.
Lupala CS; Ye Y; Chen H; Su XD; Liu H
Biochem Biophys Res Commun; 2022 Jan; 590():34-41. PubMed ID: 34968782
[TBL] [Abstract][Full Text] [Related]
36. Dynamics of binding ability prediction between spike protein and human ACE2 reveals the adaptive strategy of SARS-CoV-2 in humans.
Xue X; Shi J; Xu H; Qin Y; Yang Z; Feng S; Liu D; Jian L; Hua L; Wang Y; Zhang Q; Huang X; Zhang X; Li X; Chen C; Guo J; Tang W; Liu J
Sci Rep; 2021 Feb; 11(1):3187. PubMed ID: 33542420
[TBL] [Abstract][Full Text] [Related]
37. SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression.
Niemeyer D; Stenzel S; Veith T; Schroeder S; Friedmann K; Weege F; Trimpert J; Heinze J; Richter A; Jansen J; Emanuel J; Kazmierski J; Pott F; Jeworowski LM; Olmer R; Jaboreck MC; Tenner B; Papies J; Walper F; Schmidt ML; Heinemann N; Möncke-Buchner E; Baumgardt M; Hoffmann K; Widera M; Thao TTN; Balázs A; Schulze J; Mache C; Jones TC; Morkel M; Ciesek S; Hanitsch LG; Mall MA; Hocke AC; Thiel V; Osterrieder K; Wolff T; Martin U; Corman VM; Müller MA; Goffinet C; Drosten C
PLoS Biol; 2022 Nov; 20(11):e3001871. PubMed ID: 36383605
[TBL] [Abstract][Full Text] [Related]
38. Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context.
Tragni V; Preziusi F; Laera L; Onofrio A; Mercurio I; Todisco S; Volpicella M; De Grassi A; Pierri CL
EPMA J; 2022 Mar; 13(1):149-175. PubMed ID: 35013687
[TBL] [Abstract][Full Text] [Related]
39. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
[TBL] [Abstract][Full Text] [Related]
40. Mutational Effect of Some Major COVID-19 Variants on Binding of the S Protein to ACE2.
Li Z; Zhang JZH
Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
